These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38251257)

  • 1. TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA.
    Garamszegi SP; Brzostowicki DJ; Coyne TM; Vontell RT; Davis DA
    Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38251257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMAA, Methylmercury, and Mechanisms of Neurodegeneration in Dolphins: A Natural Model of Toxin Exposure.
    Davis DA; Garamszegi SP; Banack SA; Dooley PD; Coyne TM; McLean DW; Rotstein DS; Mash DC; Cox PA
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanobacterial neurotoxin BMAA and brain pathology in stranded dolphins.
    Davis DA; Mondo K; Stern E; Annor AK; Murch SJ; Coyne TM; Brand LE; Niemeyer ME; Sharp S; Bradley WG; Cox PA; Mash DC
    PLoS One; 2019; 14(3):e0213346. PubMed ID: 30893348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.
    Scott LL; Downing TG
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29286334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.
    Kazemi Shariat Panahi H; Dehhaghi M; Heng B; Lane DJR; Bush AI; Guillemin GJ; Tan VX
    Neurotox Res; 2022 Apr; 40(2):614-635. PubMed ID: 35023054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of β-N-methylamino-l-alanine in postmortem olfactory bulbs of Alzheimer's disease patients using UHPLC-MS/MS: An autopsy case-series study.
    Garamszegi SP; Banack SA; Duque LL; Metcalf JS; Stommel EW; Cox PA; Davis DA
    Toxicol Rep; 2023; 10():87-96. PubMed ID: 36691605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.
    Ra D; Sa B; Sl B; Js M; Sj M; DA D; Ew S; O K; Eb B; Ad C; Vx T; Gg G; Pa C; Dc M; Wg B
    Neurotox Res; 2021 Feb; 39(1):81-106. PubMed ID: 33547590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination.
    Porojan C; Mitrovic SM; Yeo DC; Furey A
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Oct; 33(10):1570-1586. PubMed ID: 27652898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.
    Cox PA; Davis DA; Mash DC; Metcalf JS; Banack SA
    Proc Biol Sci; 2016 Jan; 283(1823):. PubMed ID: 26791617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the suspected neurotoxin β-methylamino-l-alanine (BMAA) in cyanobacterial blooms from multiple water bodies in Eastern Australia.
    Main BJ; Bowling LC; Padula MP; Bishop DP; Mitrovic SM; Guillemin GJ; Rodgers KJ
    Harmful Algae; 2018 Apr; 74():10-18. PubMed ID: 29724339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND.
    Davis DA; Cox PA; Banack SA; Lecusay PD; Garamszegi SP; Hagan MJ; Powell JT; Metcalf JS; Palmour RM; Beierschmitt A; Bradley WG; Mash DC
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):393-406. PubMed ID: 32077471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
    Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
    Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
    Banack SA; Caller TA; Stommel EW
    Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Changes in Cyanobacterial Concentration of β-Methylamino-L-Alanine during a Bloom Event.
    Peters SJ; Rodgers KJ; Mitrovic SM; Bishop DP
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.